Sodium channel in human malignant hyperthermia

Anesthesiology

Volumn 86, Issue 5, 1997, Pages 1023-1032

  Fletcher, Jeffrey E ^a   Wieland, Steven J ^a   Karan, Steven M ^b   Beech, Jill ^c   Rosenberg, Henry ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anesthetics, volatile; Hyperthermia, malignant; Rigidity, muscle; Sodium channel; Succinylcholine

Indexed keywords

INHALATION ANESTHETIC AGENT; MESSENGER RNA; SODIUM CHANNEL; SUXAMETHONIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUSCLE RIGIDITY; MUSCLE TWITCH; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0031005274     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199705000-00004     Document Type: Article

References (47)

1. Gronert GA: Malignant hyperthermia. Myology, 2nd edition. Edited by Engel AG, Franzini-Armstrong C. New York, McGraw-Hill, 1994, pp. 1661-78
2. Allen GC: Malignant hyperthermia susceptibility. Temperature Regulation during Anesthesia. Edited by Levitt RC. Anesthesiology Clinics of North America. Philadelphia, WB Saunders, 1994, pp. 513-35
3. Rosenberg H, Fletcher JE, Seitman D: Pharmacogenetics. Clinical Anesthesia, 3rd edition. Edited by Barash PG, Cullen BF, Stoelting RK. Philadelphia, Lippincott-Raven Publishers, 1996, pp. 489-517
4. MacLennan DH, Phillips MS: Malignant hyperthermia. Science 1992; 256:789-94
5. Fletcher JE, Calvo PA, Rosenberg H: Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation. Br J Anaesth 1993; 71:410-7
6. Fletcher JE, Tripolitis L, Hubert M, Vita GM, Levitt RC, Rosenberg H: Genotype and phenotype relationships for mutations in the ryanodine receptor in patients referred for diagnosis of malignant hyperthermia. Br J Anaesth 1995; 75:307-10
7. 2+ and meat quality in young and adult halothane-sensitive and halothane-insensitive British Landrace pigs. Meat Science 1986; 17:37-53
8. Wieland SJ, Fletcher JE, Rosenberg H, Gong QH: Malignant hyperthermia: slow sodium current in cultured human muscle cells. Am J Physiol 1989; 257:C759-65
9. Wieland SJ, Gong Q-H, Fletcher JE, Rosenberg H: Altered sodium current response to intracellular fatty acids in halothane-hypersensitive skeletal muscle. Am J Physiol 1996; 271:C347-53
10. Kallen RG, Cohen SA, Barchi RL: Structure, function and expression of voltage-dependent sodium channels. Mol Neurobiol 1994; 7:383-428
11. Barchi RL: Molecular pathology of the skeletal muscle sodium channel. Annu Rev Physiol 1995; 57:355-85
12. Cannon SC: Sodium channel defects in myotonia and and periodic paralysis. Ann Rev Neurosci 1996; 19:141-64
13. Wieland SJ, Gong Q-H, Poblete H, Fletcher JE, Chen L-Q, Kallen RG: Modulation of human muscle sodium channels by intracellular fatty acids is dependent on the channel isoform. J Biol Chem 1996; 271:19037-41
14. Redfern P, Lund H, Thesleff S: Tetrodotoxin resistant action potentials in denervated rat skeletal muscle. Eur J Pharmacol 1970; 11:263-5
15. Redfern P, Thesleff S: Action potential generation in denervated rat skeletal muscle. H. The action of tetrodotoxin. Acta Physiol Scand 1971; 82:70-8
16. Fletcher JE, Rosenberg H: In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity. ANESTHESIOLOGY 1985; 63:190-4
17. Larach MG: Standardization of the caffeine halothane muscle contracture test. Anesth Analg 1989; 69:511-5
18. Fletcher JE: Current laboratory methods for the diagnosis of malignant hyperthermia susceptibility. Edited by Levitt RC. Anesthesiology Clinics of North America. Temperature Regulation During Anesthesia. Philadelphia, WB, Saunders, 1994, pp. 553-70
19. Allen GC, Fletcher JE, Huggins FJ, Conti PA, Rosenberg H: Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group. ANESTHESIOLOGY 1990; 72:71-6
20. Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J: In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles. Anesth Analg 1996; 82:1230-6
21. Fletcher JE, Conti PA, Rosenberg H: Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols. Acta Anaesthesiol Scand 1991; 35:483-7
22. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, John Wiley & Sons, 1994
23. Hood DA, Simoneau J-A: Rapid isolation of total RNA from small mammal and human skeletal muscle. Am J Physiol 1989; 256:C1092-6
24. Narahashi T: Chemicals as tools in the study of excitable membranes. Physiol Rev 1974; 54:813-89
25. Chahine M, Bennett PB, George AL Jr, Horn R: Functional expression and properties of the human skeletal muscle sodium channel. Pflugers Arch 1994; 427:136-42
26. + channel. Mol Pharmacol 1991; 39:604-8
27. Levitt RC, Nouri N, Jedlicka AE, McKusick VA, Marks AR, Shutack JG, Fletcher JE, Rosenberg H, Meyers DA: Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics 1991; 11:543-7
28. Hogan K: Prospects for the noninvasive presymptomatic diagnosis of malignant hyperthermia susceptibility using molecular genetic techniques. Temperature Regulation During Anesthesia. Edited by Levitt RC. Anesthesiology Clinics of North America. Philadelphia, WB Saunders, 1994, pp. 571-98
29. Ervasti JM, Claessens MT, Mickelson JR, Louis CF: Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia. J Biol Chem 1989; 264:2711-7
30. Mickelson JR, Ervasti JM, Litterer LA, Campbell KP, Louis CF: Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes. Am J Physiol 1994; 267:C282-92
31. 2+ regulation defects. Physiol Rev 1996; 76:537-92
32. Walsh MP, Brownell AKW, Littmann V, Paasuke RT: Electrophoresis of muscle proteins is not a method for diagnosis of malignant hyperthermia susceptibility. ANESTHESIOLOGY 1986; 64:473-9
33. Iaizzo PA, Lehmann-Horn F, Taylor SR, Gallant EM: Malignant hyperthermia: effects of halothane on the surface membrane. Muscle Nerve 1989; 12:178-83
34. Ruppersberg JP, Rüdel R: Differential effects of halothane on adult and juvenile sodium channels in human muscle. Pflugers Arch 1988; 412:17-21
35. Wang DW, George Jr AL, Bennet PH: Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J 1996; 70:238-45
36. 2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle. Res Commun Chem Pathol Pharm 1992; 77:253-6
37. Hartung E, Zoererbauer M, Anetseder M, Engelhardt W: Mepivacaine reduces viability and produces contractures in malignant hyperthermia susceptible and normal muscle. ANESTHESIOLOGY 1996; 85:A803
38. 2+ alter responses of cat muscle to halothane and caffeine. J Appl Physiol 1986; 60:935-41
39. Heiman-Patterson TD, Fletcher JE, Rosenberg H, Tahmoush AJ: No relationship between fiber type and halothane contracture test results in malignant hyperthermia. ANESTHESIOLOGY 1987; 67:82-4
40. Haimovich B, Schotland DL, Fieles WE, Barchi RL: Localization of sodium channel subtypes in adult rat skeletal muscle using channel-specific monoclonal antibodies. J Neurosci 1987; 7:2957-66
41. Milton RL, Behforouz MA: Na+ channel density in extrajunctional sarcolemma of fast and slow twitch mouse skeletal muscle fibres: functional implications and plasticity after fast motoneuron transplantation on to a slow muscle. J Musc Res Cell Motil 1995; 16:430-9
42. Vital Brazil O, Fontana MD: Review article - Toxins as tools in the study of sodium channel distribution in the muscle fibre membrane. Toxicon 1993; 31:1085-98
43. Fletcher JE, Rosenberg H: In vitro muscle contractures induced by halothane and suxamethonium: H. Human skeletal muscle from normal and malignant hyperthermia susceptible patients. Br J Anaesth 1986; 58:1433-9
44. Wieland SJ, Fletcher JE, Gong Q-H: Differential modulation of a sodium conductance in skeletal muscle by intracellular and extracellular fatty acids. Am J Physiol 1992; 263:C308-12
45. Russell SH, Hirsch NP: Anaesthesia and myotonia. Br J Anaesth 1994; 72:210-6
46. Paterson IS: Generalized rigidity following suxamethonium. A case report. Br J Anaesth 1962; 34:340-2
47. Morley JB, Lambert TF, Kakulas BA: A case of hyperpyrexia with myotonia congenita. Exer Med Intl Congr Ser 1973; 295:543-6